MA15.11 Neoadjuvant Sintilimab Plus Chemotherapy in EGFR-mutant NSCLC Followed by Adjuvant Osimertinib or Observation: A Phase II CTONG2104 Trial
Journal of Thoracic Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined